Andrew Davis

Andrew Davis

Företagsledare/Principal på DYNAVAX TECHNOLOGIES CORPORATION
40 år
Health Technology
Consumer Services

Profil

Andrew Davis is currently Director at UTILITY therapeutics Ltd. since 2019 and Chief Business Officer at Dynavax Technologies Corp.
starting in 2024.
Formerly, Mr. Davis was Chairman at VectivBio Holding AG; Director at BioMarck Pharmaceuticals Ltd. from 2020 to 2022; Senior Vice President-Business Development at Ironwood Pharmaceuticals, Inc. in 2021; Senior Vice President-Business Development at Bausch Health US LLC from 2014 to 2016; Vice President-Corporate Development at Bausch Health Cos., Inc.; Chief Business Development Officer at iNova Pharmaceuticals (Pty) Ltd. (South Africa) from 2017 to 2021; and Head-Oncology Business Development at Merck & Co., Inc. from 2016 to 2017.
Education includes undergraduate studies at Boston University.

Aktiva positioner av Andrew Davis

FöretagPositionStart
DYNAVAX TECHNOLOGIES CORPORATION Företagsledare/Principal 2024-11-01
Direktör/Styrelseledamot 2019-08-01

Tidigare kända positioner av Andrew Davis

FöretagPositionSlut
IRONWOOD PHARMACEUTICALS, INC. Företagsledare/Principal 2024-11-22
Direktör/Styrelseledamot 2022-10-01
Företagsledare/Principal 2021-05-01
MERCK & CO., INC. Företagsledare/Principal 2017-09-01
Företagsledare/Principal 2016-01-01
Se detaljerna i Andrew Daviss erfarenhet

Andrew Daviss utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

15

Första gradens relationer

10

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag10

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Andrew Davis